Treatment of two cases of COVID-19 with ciclesonide resulted in amelioration of pneumonia symptoms

Tomoya Tsuchida; Yukitaka Yamasaki; Hiroyuki Kunishima; Kentaro Sato; Minoru Kanazawa; Asami Moriuchi; Daiki Morikawa; Mumon Takita; Yoshiyuki Naito; Shuichi Fujii; Shigeki Fujitani; Takahide Matsuda

doi:10.11553/antibiotics.73.2_35

症例報告

Treatment of two cases of COVID-19 with ciclesonide resulted in amelioration of pneumonia symptoms

Tomoya Tsuchida, Yukitaka Yamasaki, Hiroyuki Kunishima, Kentaro Sato, Minoru Kanazawa, Asami Moriuchi, Daiki Morikawa, Mumon Takita, Yoshiyuki Naito, Shuichi Fujii, Shigeki Fujitani, Takahide Matsuda

著者情報

Tomoya Tsuchida
Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine
Yukitaka Yamasaki
Department of Infectious Diseases, St. Marianna University School of Medicine
Hiroyuki Kunishima
Department of Infectious Diseases, St. Marianna University School of Medicine
Kentaro Sato
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Minoru Kanazawa
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Asami Moriuchi
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Daiki Morikawa
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Mumon Takita
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Yoshiyuki Naito
Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine
Shuichi Fujii
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Shigeki Fujitani
Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine
Takahide Matsuda
Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine

ジャーナルフリー

2020 年 73 巻 2 号 p. 35-44

DOI https://doi.org/10.11553/antibiotics.73.2_35

詳細

抄録

We have observed two cases in which ciclesonide, an inhaled steroid drug for bronchial asthma, had a possibly useful effect on novel coronavirus disease (coronavirus disease 2019: COVID-19) pneumonia. Our observations suggest that ciclesonide treatment may ameliorate the clinical symptoms of COVID-19; however, further studies on a larger number of cases are required to confirm the therapeutic effects of ciclesonide

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）